-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MM-402 in Autism Spectrum Disorder (ASD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MM-402 in Autism Spectrum Disorder (ASD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MM-402 in Autism Spectrum Disorder (ASD) Drug Details: Midomafetamine (MM-402)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MM-10001 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MM-10001 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MM-10001 in Non-Small Cell Lung Cancer Drug Details: MM-10001 (beta-glucan)...
-
Product Insights
Likelihood of Approval Analysis for Hypereosinophilic Syndrome
Overview How likely is it that the drugs in Hypereosinophilic Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypereosinophilic Syndrome Overview Hypereosinophilic syndrome (HES) is a disease characterized by a...
-
Product Insights
MM Prima Deshecha Biogas Power Plant
MM Prima Deshecha Biogas Power Plant is a biopower project located in California, United States. The project is owned by MM Prima Deshecha Energy LLC. The project came online in 2002. Empower your strategies with our MM Prima Deshecha Biogas Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
NewNet Present Value Model: Mind Medicine MindMed Inc’s MM-120
Empower your strategies with our Net Present Value Model: Mind Medicine MindMed Inc's MM-120 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Mind Medicine MindMed Inc’s MM-290
Empower your strategies with our Net Present Value Model: Mind Medicine MindMed Inc's MM-290 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OPC-415 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPC-415 in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPC-415 in Relapsed Multiple Myeloma Drug Details: OPC-415 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OPC-415 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPC-415 in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPC-415 in Refractory Multiple Myeloma Drug Details: OPC-415 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CFT-7455 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CFT-7455 in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CFT-7455 in Mantle Cell Lymphoma Drug Details: CFT-7455 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CFT-7455 in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CFT-7455 in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CFT-7455 in Follicular Lymphoma Drug Details: CFT-7455 is under development for the...